Mouse genome rewriting and tailoring of three important disease loci.
Ontology highlight
ABSTRACT: Genetically engineered mouse models (GEMMs) help us to understand human pathologies and develop new therapies, yet faithfully recapitulating human diseases in mice is challenging. Advances in genomics have highlighted the importance of non-coding regulatory genome sequences, which control spatiotemporal gene expression patterns and splicing in many human diseases1,2. Including regulatory extensive genomic regions, which requires large-scale genome engineering, should enhance the quality of disease modelling. Existing methods set limits on the size and efficiency of DNA delivery, hampering the routine creation of highly informative models that we call genomically rewritten and tailored GEMMs (GREAT-GEMMs). Here we describe 'mammalian switching antibiotic resistance markers progre
SUBMITTER: Zhang W
PROVIDER: S-EPMC10632133 | biostudies-literature | 2023 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA